Source: PR Newswire

Press Release: Nucleus Biologics : Nucleus Biologics Obtains ISO 13485:2016 Certification

ISO 13485:2016 certification demonstrates Nucleus Biologics' commitment to maintaining premium quality standards. SAN DIEGO, Aug. 23, 2022 /PRNewswire/ -- Nucleus Biologics, The Cell Performance Company , the industry-leading provider of small lot custom media for the cell and gene...

Read full article »
Nucleus Biologics's Competitors | Nucleus Biologics's News | Nucleus Biologics's Financials
Stay up-to-date with the latest news on Nucleus Biologics
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
David Sheehan's photo - President & CEO of Nucleus Biologics

President & CEO

David Sheehan

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Nucleus Biologics